ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 9, 2014, Pages E1784-E1792

  Gagliardi, Lucia ^a,b   Schreiber, Andreas W ^a,b   Hahn, Christopher N ^a,b   Feng, Jinghua ^a,b   Cranston, Treena ^c   Boon, Hannah ^c   Hotu, Cheri ^e   Oftedal, Bergithe E ^a,f   Cutfield, Richard ^g   Adelson, David L ^b   Braund, Wilton J ^h   Gordon, Richard D ^i,j   Rees, D Aled ^k   Grossman, Ashley B ^d   Torpy, David J ^a,b   Scott, Hamish S ^a,b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e GREEN LANE HOSPITAL   (New Zealand)

^f UNIVERSITY OF BERGEN   (Norway)

^g NORTH SHORE HOSPITAL   (New Zealand)

^h FLINDERS MEDICAL CENTRE   (Australia)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

^j PRINCESS ALEXANDRA HOSPITAL   (Australia)

^k CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; HYDROCORTISONE; VASOPRESSIN; ARMC5 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADRENAL HYPERPLASIA; ADULT; AGED; ARMC5 GENE; ARTICLE; CLINICAL ARTICLE; DRUG RESPONSE; EXOME; EXON; FAMILIAL BILATERAL MACRONODULAR ADRENAL HYPERPLASIA; FAMILIAL DISEASE; FEMALE; GENE; GENE DOSAGE; GENE MUTATION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GERM LINE; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; PHENOTYPE; SEGREGATION ANALYSIS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STEROIDOGENESIS; CONGENITAL ADRENAL HYPERPLASIA; CUSHING SYNDROME; FAMILY HEALTH; GENETIC ASSOCIATION; GENETICS; GERMLINE MUTATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ADRENAL HYPERPLASIA, CONGENITAL; ADULT; AGED; BASE SEQUENCE; CUSHING SYNDROME; EXOME; FAMILY HEALTH; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHENOTYPE; TUMOR SUPPRESSOR PROTEINS;

EID: 84907199509     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-1265     Document Type: Article

References (33)

1. Kirschner MA, Powell Jr RD, Lipsett MB. Cushing's syndrome: Nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumour. J Clin Endocrinol (Oxf). 1964;24:947-955.
2. Lacroix A. ACTH-independent macronodular adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab. 2009;23:245-259.
3. Lacroix A, Bolté E, Tremblay J, et al. Gastric inhibitory polypeptidedependent cortisol hypersecretion-a new cause of Cushing's syndrome. N Engl J Med. 1992;327:974-980.
4. Reznik Y, Allali-Zerah V, Chayvialle JA, et al. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med. 1992;327:981-986.
5. Lacroix A, Tremblay J, Touyz RM, et al. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. J Clin Endocrinol Metab. 1997;82:2414-2422.
6. Horiba N, Suda T, Aiba M, et al. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab. 1995; 80:2336-2341.
7. Arnaldi G, Gasc JM, de Keyzer Y, et al. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid- secreting adrenocortical tumors. J Clin Endocrinol Metab. 1998;83:2029-2035.
8. Miyamura N, Taguchi T, Murata Y, et al. Inherited adrenocorticotropin- independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland. Endocrine. 2002;19:319-325.
9. Lee S, Hwang R, Lee J, et al. Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia. Clin Endocrinol (Oxf). 2005;63:625-630.
10. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. Propranolol therapy for ectopic α-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med. 1997;337:1429-1434.
11. Lacroix A, Mircescu H, Hamet P. Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing's syndrome. Endocrinologist. 1999;9:9-15.
12. Lefebvre H, Duparc C, Chartrel N, et al. Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab. 2003;88:3035-3042.
13. Mazzuco TL, Thomas M, Martinie M, et al. Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing betablocker- sensitive Cushing's syndrome. Arq Bras Endocrinol Metab. 2007;51:1452-1462.
14. Louiset E, Duparc C, Young J, et al. Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N Engl J Med. 2013; 369:2115-2125.
15. N'Diaye N, Hamet P, Tremblay J, Boutin JM, Gaboury L, Lacroix A. Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing's syndrome. J Clin Endocrinol Metab. 1999;84:2616-2622.
16. Lieberman SA, Eccleshall TR, Feldman D. ACTH-independent massive bilateral adrenal disease (AIMBAD): a subtype of Cushing's syndrome with major diagnostic and therapeutic implications. Eur J Endocrinol. 1994;131:67-73.
17. Swain JM, Grant CS, Schlinkert RT, et al. Corticotropin-independent macronodular adrenal hyperplasia: a clinicopathologic correlation. Arch Surg. 1998;133:541-545; discussion 545-546.
18. Ghayee HK, Rege J, Watumull LM, et al. Clinical, biochemical, and molecular characterization of macronodular adrenocortical hyperplasia of the zona reticularis: a new syndrome. J Clin Endocrinol Metab. 2011;96:E243-E250.
19. Goodarzi MO, Dawson DW, Li X, et al. Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone. J Clin Endocrinol Metab. 2003;88:73-77.
20. Malchoff CD, Rosa J, DeBold CR, et al. Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: an unusual cause of Cushing's syndrome. J Clin Endocrinol Metab. 1989;68: 855-860.
21. Findlay JC, Sheeler LR, Engeland WC, Aron DC. Familial Adrenocorticotropin- Independent Cushing's Syndrome with bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab. 1993; 76:189-191.
22. Minami S, Sughihara H, Sato J, et al. ACTH independent Cushing's syndrome occurring in siblings. Clin Endocrinol (Oxf). 1996;44: 483-488.
23. Nies C, Bartsch DK, Ehlenz K, et al. Familial ACTH-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia clinically affecting only female family members. Exp Clin Endocrinol Diabetes. 2002;110:277-283.
24. Vezzosi D, Cartier D, Régnier C, et al. Familial adrenocorticotropinindependent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur J Endocrinol. 2007; 156:21-31.
25. Gagliardi L, Hotu C, Casey G, et al. Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-BMAH): clinical studies of three kindreds. Clin Endocrinol (Oxf). 2009;70:883-891.
26. Assié G, Libé R, Espiard S, et al. ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome. N Engl J Med. 2013;369:2105-2114.
27. Faucz FR, Zilbermint M, Lodish MB, et al. Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation. J Clin Endocrinol Metab. 2014;99(6):E1113-E1119.
28. Aiba M, Hirayama A, Iri H, et al. Adrenocorticotropic hormoneindependent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing's syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature. Am J Clin Pathol. 1991;96:334-340.
29. Sukor N, Gordon RD, Ku YK, Jones M, Stowasser M. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab. 2009;94:2437-2445.
30. Hsiao HP, Kirschner LS, Bourdeau I, et al. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. J Clin Endocrinol Metab. 2009;94:2930-2937.
31. Horvath A, Giatzakis C, Robinson-White A, et al. Adrenal hyperplasia and adenomas are associated with inhibition of phosphodiesterase 11A in carriers of PDE11A sequence variants that are frequent in the population. Cancer Res. 2006;66:11571-11575.
32. Alencar GA, Lerario AM, Nishi MY, et al. ARMC5 mutations are a frequent cause of primary macronodular adrenal hyperplasia [published online April 7, 2014]. J Clin Endocrinol Metab. doi: 10.1210/jc.2013-4237.
33. Cao Y, He M, Gao Z, Peng Y, Li Y, Li L, Zhou W, Li X, Zhong X, Lei Y, Su T, Wang H, Jiang Y, Yang L, Wei W, Yang X, Jiang X, Liu L, He J, Ye J, Wei Q, Li Y, Wang W, Wang J, Ning G. Activating hotspot L205R mutation in PRKACA and Adrenal Cushing's syndrome. Science. 2014;344(6186):913-917.